GAITHERSBURG, Md., Sept. 05, 2017 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in Citi’s 12th Annual Biotech Conference.
Conference details are as follows:
Date: Thursday, September 7, 2017
Location: Mandarin Oriental hotel, Boston, MA
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company’s website, novavax.com.
Andrea N. Flynn, Ph.D.
Director, Investor Relations
Doctors Discover How To Reverse Diabetes. Learn More
Survival Things Our Great-Grandfathers Did Around The House. Watch Video
The Safest Investment In Uncertain Times Is Gold. Get Started Here!